Delivery Order SPE2DB22D3016-SPE2DB24FARJ7
Award Date
4/1/24
Potential Completion Date
4/2/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,467.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to procure 4,566,108,720 units of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently acquire a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medical products. The fixed-price contract has a ceiling value of $8,422.79 and an ultimate completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, and has a total ceiling value of $16,773.40. The contract is a firm fixed-price delivery order with a performance period ending on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $5,607.17 firm-fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4,565,321,019 units of Budesonide-Formoterol 80-4.5 10.2GM, a critical pharmaceutical product. This delivery order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,747,323 units of the drug Budesonide-Formoterol 160-4.5 10.2GM, with a ceiling value of $1,696.32 and a period of performance through December 18, 2024. This contract is not designated as a set-aside and is a firm-fixed-price delivery order under a larger Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,515.72, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,515.72, and an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a $6,358.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a period of performance through September 24, 2024. This delivery order is likely under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA to...
This is a $7,588.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication, with an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to...